Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.61 USD | +0.71% | +0.97% | +45.89% |
02/05 | Immunome, Inc. Appoints Kinney Horn as Chief Business Officer | CI |
30/04 | JPMorgan Starts Immunome With Overweight Rating, $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.89% | 929M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Wedbush Raises Immunome's PT to $19 From $12 After Acquiring IM-1021 From Zentalis Pharmaceuticals, Maintains Outperform Rating